340B contract pharmacy restrictions, manufacturer claims-level data demands, and ongoing litigation continue to reshape the 340B Drug Pricing Program.
What do these developments mean for covered entities, hospitals, health centers, and contract pharmacies?
In this Frier Levitt webinar, Frier Levitt attorneys Jesse C. Dresser and Geordan L. Ferguson discuss the evolving legal and regulatory landscape surrounding the federal 340B Drug Pricing Program, including manufacturer-imposed restrictions, claims-data requirements, litigation, and emerging policy developments.
Watch the webinar for insights on:
- 340B Contract Pharmacy Restrictions: How manufacturer policies are evolving and the potential impact on covered entities and their pharmacy relationships.
- Claims-Level Data Requirements: Legal and operational considerations when manufacturers require claims data as a condition of 340B pricing.
- Alternative Distribution Models (ADMs): How these models operate and the potential risks for 340B stakeholders.
- 340B Litigation: Recent legal challenges and their potential implications.
- Administrative Dispute Resolution: The potential avenues for challenging manufacturer restrictions.
- State 340B Legislation: How states are responding to manufacturer restrictions and claims-data policies.
- HRSA’s 340B Rebate Model Pilot: Developments and potential implications for covered entities, pharmacies, and other 340B stakeholders.
Who should watch:
This webinar is relevant to hospitals, federally qualified health centers (FQHCs), other 340B covered entities, contract pharmacies, healthcare executives, pharmacy leaders, compliance professionals, and legal counsel navigating the complexities of the 340B Drug Pricing Program.
Complete the form below to access the webinar:
Watch Webinar Series: 340B Contract Pharmacy Restrictions: Manufacturer Demands, Claims Data & Litigation
Presenters:
Jesse C. Dresser
Jesse represents pharmacy providers nationwide, including community, specialty, and home infusion pharmacies. His practice focuses on pharmacy law, drug pricing, and the legal and economic challenges facing the pharmacy industry. He frequently speaks at national and regional healthcare conferences and industry webinars.
Geordan L. Ferguson
Geordan represents and advises 340B covered entities, contract pharmacies, wholesalers, distributors, and other healthcare providers in litigation and arbitration matters.
Why Frier Levitt
Frier Levitt is a national boutique law firm serving clients across the healthcare, life sciences, and pharmacy industries. Our attorneys work directly with 340B covered entities, hospitals, health systems, and pharmacies to address manufacturer restrictions, contract pharmacy disputes, audits, reimbursement challenges, and regulatory compliance matters.
With experience representing 340B stakeholders in complex litigation and disputes involving major industry participants, our team brings a practical understanding of the legal, financial, and operational issues affecting 340B programs. We help clients evaluate their rights, assess potential risks, and develop strategies to protect their interests as manufacturer policies and regulatory requirements evolve.
